4 Fabry Disease Clinical Trials in Minneapolis, MN (2026)

Q: Are there fabry disease clinical trials in Minneapolis?

Yes, there are 4 fabry disease clinical trials currently recruiting in Minneapolis, MN.

Q: How do I join a clinical trial in Minneapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you.

Q: Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Fabry Disease Studies in Minneapolis

NCT01581424Recruiting

Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study

The investigators will perform a study with two major components. The first is a natural history study of untreated Fabry patients. This study component will detail kidney microscopic structural chang...

Minneapolis, MN50 participantsUniversity of Minnesota

View Study Details

NCT06270316Recruiting

Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease

The main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people wi...

Minneapolis, MNPHASE120 participantsUniQure Biopharma B.V.

View Study Details

NCT06858397Recruiting

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD....

Minneapolis, MNPHASE118 participantsGC Biopharma Corp

View Study Details

NCT06904261Recruiting

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

An open-label study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of migalastat treatment in pediatric subjects 2 to \< 12 years of age with Fabry disease and with...

Minneapolis, MNPHASE38 participantsAmicus Therapeutics

View Study Details

About Fabry Disease Clinical Trials in Minneapolis

Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.

There are currently 4 fabry disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 96 participants. Research is being sponsored by University of Minnesota, UniQure Biopharma B.V., GC Biopharma Corp and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fabry Disease Clinical Trials in Minneapolis — FAQ

Are there fabry disease clinical trials in Minneapolis?

Yes, there are 4 fabry disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What fabry disease treatments are being tested?

The 4 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.

Data updated October 12, 2026 from ClinicalTrials.gov